Axial SpA – What is New?

Mikkel Østergaard’s presentation at SCR 2023 covers recent developments in the management of axial spondyloarthritis (axSpA), including ASAS-EULAR international recommendations on the use of TNF inhibitors, IL-17 inhibitors, and JAK inhibitors and the impact of NSAIDs on MRI results.